Saffron supplement improves retinal flicker sensitivity

Article

Short-term saffron supplementation has been found to improve retinal flicker sensitivity in early age-related macular degeneration (AMD).

Short-term saffron supplementation has been found to improve retinal flicker sensitivity in early age-related macular degeneration (AMD), according to a study recently published in Investigative Ophthalmology & Visual Science.

The study, led by Dr Benedetto Falsini of the Universita' Cattolica del S. Cuore, Rome, Italy, aimed to evaluate the functional effect that short-term saffron supplementation may have on early AMD.

A group of 25 patients with AMD were randomly assigned to oral saffron 20 mg/d or placebo supplementation for 3 months and then reverted to the reverse treatment for another 3 months. Focal electroretinograms (fERGs) and clinical findings were recorded at baseline and then after 3 months of treatment with saffron or placebo supplementation.

After the patients had received saffron supplementation their fERGs increased in amplitude compared with the baseline or those on the placebo treatment. Additionally, the fERG thresholds were decreased after saffron supplementation but not placebo.

These results show that the short-term use of saffron supplementation improves retinal flicker sensitivity in early AMD. However, these results need to be replicate and the clinical significance has not yet been quantified. Overall, the study has provided important clues that the nutritional carotenoids found in saffron may affect AMD in ways that may be beyond their antioxidant properties.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.